Counterpoint Mutual Funds LLC Increases Position in Oscar Health, Inc. (NYSE:OSCR)

Counterpoint Mutual Funds LLC lifted its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 95.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,994 shares of the company’s stock after purchasing an additional 23,960 shares during the quarter. Oscar Health accounts for 0.2% of Counterpoint Mutual Funds LLC’s portfolio, making the stock its 9th largest position. Counterpoint Mutual Funds LLC’s holdings in Oscar Health were worth $729,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Prevail Innovative Wealth Advisors LLC acquired a new stake in shares of Oscar Health during the fourth quarter worth $92,000. Handelsbanken Fonder AB acquired a new stake in shares of Oscar Health during the fourth quarter worth $110,000. Focus Financial Network Inc. ADV acquired a new stake in shares of Oscar Health during the fourth quarter worth $152,000. Victory Capital Management Inc. raised its holdings in shares of Oscar Health by 37.7% during the fourth quarter. Victory Capital Management Inc. now owns 18,852 shares of the company’s stock worth $172,000 after acquiring an additional 5,159 shares during the period. Finally, Nomura Holdings Inc. acquired a new stake in shares of Oscar Health during the fourth quarter worth $179,000. 75.70% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Wells Fargo & Company lifted their price target on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Baird R W upgraded shares of Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Raymond James assumed coverage on shares of Oscar Health in a research note on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target on the stock. Bank of America reiterated a “neutral” rating and issued a $21.00 price target (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Finally, The Goldman Sachs Group boosted their price objective on shares of Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a research note on Thursday, May 9th. Three research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $19.75.

Insider Buying and Selling

In related news, insider Mario Schlosser sold 5,808 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $113,023.68. Following the completion of the transaction, the insider now directly owns 65,920 shares in the company, valued at approximately $1,282,803.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Mario Schlosser sold 5,808 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $113,023.68. Following the completion of the transaction, the insider now directly owns 65,920 shares in the company, valued at approximately $1,282,803.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $362,092.22. Following the completion of the transaction, the chief operating officer now owns 65,316 shares of the company’s stock, valued at $1,271,049.36. The disclosure for this sale can be found here. Insiders sold a total of 81,655 shares of company stock worth $1,589,006 in the last three months. 25.11% of the stock is owned by corporate insiders.

Oscar Health Stock Up 1.6 %

Shares of Oscar Health stock traded up $0.29 on Wednesday, reaching $17.93. 2,274,541 shares of the stock were exchanged, compared to its average volume of 3,303,651. The firm’s 50 day moving average is $19.42 and its 200-day moving average is $15.23. Oscar Health, Inc. has a one year low of $4.72 and a one year high of $23.44. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.10 and a current ratio of 1.10.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative net margin of 0.82% and a negative return on equity of 5.77%. The company had revenue of $2.14 billion during the quarter, compared to the consensus estimate of $1.99 billion. During the same quarter in the prior year, the firm posted ($0.18) EPS. The firm’s quarterly revenue was up 45.8% on a year-over-year basis. On average, sell-side analysts forecast that Oscar Health, Inc. will post -0.05 EPS for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.